Background
Methods
Participants, interventions and outcomes
Trial design
Study setting
Eligibility criteria
Mentors | |
Inclusion Criteria | Exclusion Criteria |
Age > 21 years | Cognitive or psychiatric illness precluding participation as determined by dialysis physician |
1) Receives in-center hemodialysis for ESRD for at least 1 year at one of the participating dialysis facilities; 2) No hospitalizations in previous 6 months;,and 3) No unexcused absence or shortening of dialysis treatments in the past 6 months; and 4) use of AVF/G access, and 5) serum albumin > 3.5 mg/dLin the month prior to enrollment | Less than a 6-month life expectancy |
Willing to give informed consent for 24 months of training and intervention delivery | Active substance use, excluding cannabinoids |
Speak Spanish or English | Enrolled in another Peer Support or Educational Study |
Patient Participants | |
Inclusion Criteria | Exclusion Criteria |
Age > 21 years | Cognitive or psychiatric illness precluding participation as determined by dialysis physician |
1) One or more hospitalizations or ED visits in the previous month or 2) > 1 unexcused, missed treatment or 2 shortened dialysis treatments (by greater than 10 mins) in the last month, or 3) use of catheter as only access or 4) > 4% IDWG per week at least once in the last month or 5) serum albumin less than 3.5 mg/dL in the last month or 6) initiated dialysis in past 90 days | Less than a 6-month life expectancy |
Will to give informed consent to 1) randomization and 2) telephone intervention | Active substance use, excluding cannabinoids |
Speak Spanish or English | Enrolled in another Peer Support or Educational Study |
Interventions
Mentor participants
Patient participants
Mentor-intervention patient participant matching
COVID-19 adaptations (starting from month 9 from initiation of study activities until the end of the study period)
Outcomes
Primary outcome
Secondary outcomes
Participant timeline
Sample size
Participant recruitment
Assignment of interventions
Allocation sequence, concealment and implementation
Data collection, management, and analysis
Data collection methods
-
Data regarding outcomes is collected monthly using both participant report and health records. The data is self-reported by patients during monthly phone calls made by the study coordinator. Monthly dialysis facility health records and hospital records is reviewed for each patient participant to ascertain the outcome. Dialysis adherence metrics including number of missed monthly minutes of dialysis and mean monthly IDWG are collected monthly from dialysis facility EHR.
-
Survey tools will be used during study visits (n = 3) to assess various measures and include: 1- Chronic Hemodialysis Knowledge Survey (CHeKs) [26] questionnaire with additional dialysis-specific new knowledge items (CHeKs PLUS), self-management behaviors (Kidney Disease Behavioral Index(KDBI)) [27], self-efficacy (Perceived Kidney Dialysis Self-management Scale (PKDSMS) [27]), coping behaviors (brief COPE-kidney) [28] and Multi-dimensional Scale of Perceived Social Support (MSPSS and dialysis specific social support) [29] questionnaires. Questionnaires addressing depression (CESD-R 10) [30], communication ability (Communication Assessment Tool(CAT)) [31] and healthcare quality of life (SF36 health survey)(Rand) [32], healthcare environment (Health Care Climate Questionnaire (HCCQ) Long Form) [33] are also completed.